Table 2.

Salvage chemotherapy regimens in relapsed or refractory Hodgkin lymphoma.

RegimenNo. of patientsCR,% 95% CIPR,% 95% CIORR, % 95% CIGrade 3/4 NEUT, %Grade 3/4 TCP, %Grade 3/4 VOM, %Toxic deaths, % 95% CI
*mucositis reported in 9% 
†all patients experience grade IV neutropenia 
‡5% toxic death rate included patients undergoing ASCT 
Chemotherapy regimens: BEAM, BCNU, etoposide, ara-C, melphalan; ICE, ifosfamide, carboplatin, etoposide, DHAP, dexamethasone, ara-C, cisplatin; GDP, gemcitabine, dexamethasone, cisplatin; GVD, gemcitabine, vinorelbine, doxil (liposomal doxorubicin); IEV, ifosfamide, etoposide, vinorelbine; MINE, mitoguazone, ifosfamide, vinorelbine, etoposide; IV, ifosfamide, vinorelbine. 
NS indicates not stated; NEUT, neutropenia, TCP, thrombocytopenia; VOM, vomiting 
Dexa-BEAM22  144 27 54 81 NS NS NS 
  20–34 46–62 75–87    1–9 
Mini-BEAM25  55 49 33 82 86 60 NS 
  35–63 21–47 69–91    0.1–10 
ICE67  65 26 59 85 NS NS NS 
  16–39 46–71 74–92    0–5 
DHAP q2wk28  102 21 68 89 88 69 26 
  13–29 59–77 83–95    0–4 
GDP29  23 17 52 69 13 13 
  5–39 31–73 47–87    0–15 
GVD*68  91 19 51 70 63 14 
IEV32  51 76  84 100† NS NS 
  60–88  71–93     
MINE31  157 NS NS 75 NS NS NS 
  64–84       
IV33,69  47 45 38 83 65 NS 
  30–60 25–54 69–92     
RegimenNo. of patientsCR,% 95% CIPR,% 95% CIORR, % 95% CIGrade 3/4 NEUT, %Grade 3/4 TCP, %Grade 3/4 VOM, %Toxic deaths, % 95% CI
*mucositis reported in 9% 
†all patients experience grade IV neutropenia 
‡5% toxic death rate included patients undergoing ASCT 
Chemotherapy regimens: BEAM, BCNU, etoposide, ara-C, melphalan; ICE, ifosfamide, carboplatin, etoposide, DHAP, dexamethasone, ara-C, cisplatin; GDP, gemcitabine, dexamethasone, cisplatin; GVD, gemcitabine, vinorelbine, doxil (liposomal doxorubicin); IEV, ifosfamide, etoposide, vinorelbine; MINE, mitoguazone, ifosfamide, vinorelbine, etoposide; IV, ifosfamide, vinorelbine. 
NS indicates not stated; NEUT, neutropenia, TCP, thrombocytopenia; VOM, vomiting 
Dexa-BEAM22  144 27 54 81 NS NS NS 
  20–34 46–62 75–87    1–9 
Mini-BEAM25  55 49 33 82 86 60 NS 
  35–63 21–47 69–91    0.1–10 
ICE67  65 26 59 85 NS NS NS 
  16–39 46–71 74–92    0–5 
DHAP q2wk28  102 21 68 89 88 69 26 
  13–29 59–77 83–95    0–4 
GDP29  23 17 52 69 13 13 
  5–39 31–73 47–87    0–15 
GVD*68  91 19 51 70 63 14 
IEV32  51 76  84 100† NS NS 
  60–88  71–93     
MINE31  157 NS NS 75 NS NS NS 
  64–84       
IV33,69  47 45 38 83 65 NS 
  30–60 25–54 69–92     

or Create an Account

Close Modal
Close Modal